Cargando…
Safinamide improves sleep and daytime sleepiness in Parkinson’s disease: results from the SAFINONMOTOR study
BACKGROUND AND OBJECTIVE: Some studies observed a benefit of PD patients after treatment with safinamide in some non-motor symptoms. Our aim was to analyze the effectiveness of safinamide on sleep and daytime sleepiness in Parkinson’s disease (PD) patients. MATERIAL AND METHODS: SAFINONMOTOR is a pr...
Autores principales: | Santos García, Diego, Cabo López, Iria, Labandeira Guerra, Carmen, Yáñez Baña, Rosa, Cimas Hernando, Maria I., Paz González, Jose M., Alonso Losada, Maria G., Gonzalez Palmás, Maria J., Cores Bartolomé, Carlos, Martínez Miró, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459141/ https://www.ncbi.nlm.nih.gov/pubmed/34554335 http://dx.doi.org/10.1007/s10072-021-05607-2 |
Ejemplares similares
-
Pain Improvement in Parkinson’s Disease Patients Treated with Safinamide: Results from the SAFINONMOTOR Study
por: Santos García, Diego, et al.
Publicado: (2021) -
Effectiveness of Safinamide over Mood in Parkinson’s Disease Patients: Secondary Analysis of the Open-label Study SAFINONMOTOR
por: Labandeira, Carmen M., et al.
Publicado: (2021) -
Safinamide Improves Non-Motor Symptoms Burden in Parkinson’s Disease: An Open-Label Prospective Study
por: Santos García, Diego, et al.
Publicado: (2021) -
Vortioxetine Improves Depressive Symptoms and Cognition in Parkinson’s Disease Patients with Major Depression: An Open-Label Prospective Study
por: Santos García, Diego, et al.
Publicado: (2022) -
Craniofacial Characteristics Related to Daytime Sleepiness Screened by the Paediatric Daytime Sleepiness Scale
por: Gu, Min, et al.
Publicado: (2015)